Cited by 65Smoking Behavior and CessationPharmaceutical Economics and PolicyHealthcare Regulation

Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?

Shiffman, Saul, Sweeney, Christine T.·2008·Health Policy

Abstract

Objective Review the history of the Rx-to-OTC switch of nicotine replacement therapy (NRT) in the US, outlining concerns expressed before the switch, discussing how concerns were addressed, and presenting data on the actual experience in the decade following the switch.Methods Literature review of studies examining trends in NRT utilization pre- and post-switch, the efficacy and safety of NRT in the OTC setting, and patterns of OTC NRT use.Results OTC availability of NRT increased access to and utilization of treatment. Studies show that OTC NRT has been used safely and effectively, without substantial misuse or abuse, and with continued physician engagement and wide access to proven behavioral treatment.Conclusions With other medications that challenge the traditional OTC paradigm being proposed for OTC switch, the NRT case study serves as a useful example in highlighting the potential role that Rx-to-OTC switch can play in addressing public health challenges. The NRT experience suggests that advance identification and analysis of concerns, implementation of plans to manage concerns, including appropriate marketing and post-marketing surveillance, can ensure that OTC switch of medications for behavior change and disease prevention can help minimize risks and maximize public health benefits.

Integrity signals

Registry

Crossref · 10.1016/j.healthpol.2007.08.006

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 74 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Shiffman, S., & Sweeney, C. T.
Affiliations
Pinney Associates (United States) (US)
Corresponding author
Shiffman, Saul
Venue
Health Policy
Publisher
Elsevier BV
Published
2008-04
Volume
86
Issue
1
Pages
17-26
ISSN
0168-8510 (ISSN-L)
OpenAlex
W2008165838
Cited by
65
References
74
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 3 · 2012: 12
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Locations
  • Health Policy (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
GlaxoSmithKline
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Health Professions › Health Information Management › Healthcare Regulation
Keywords
nicotine replacement therapy, over-the-counter drugs, prescription-to-over-the-counter switch, smoking cessation, drug safety, post-marketing surveillance, physician engagement, behavior therapy, public health benefits
MeSH terms
Nonprescription Drugs, Humans, Nicotine, Drug Prescriptions, Tobacco Use Disorder, United States, Smoking Cessation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review